Summary.-Host responsiveness to a progressively growing methylcholanthrene (MC) induced tumour (MC6/2) was studied at varying intervals following subcutaneous (s.c.) tumour implantation by monitoring the in vitro incorporation of tritiated thymidine (3H-TdR) into lymph node cells (LNC) undergoing stimulation in vivo and concurrently determining the total numbers of the lymphoid cells present in these organs at each of the time intervals. It was found that an initial period of rapidly increasing stimulation of DNA synthesis in lymph nodes was soon followed by the onset of a stage of decrease of this activity. Within limits, the larger the tumour inoculum the stronger the initial response. The suppression of stimulation of DNA synthesis that ensued appeared to be directly related to the tumour mass and to the dose of tumour cells implanted. The total numbers of the cells accumulating in nodes also increased initially but remained elevated during the subsequent period of tumour growth. Continued presence of the tumour was essential for the increased DNA synthesis in lymph nodes since tumour removal leads to a rapid decrease to levels found in tumour-free animals. These findings demonstrate that the failure to eradicate an antigenic tumour by its host may not be solely due to " desensitizing" and " blocking " factors but that other important mechanisms are also involved.
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We suggest that the inability to reject the tumour in this situation is dependent in considerable measure on the development of a state of hyporeactivity in the host due to the partial inhibition of the DNA synthetic response, possibly in T cells of the tumour host, due to " suppressor factor(s) " interacting with the immunocompetent cells.
EVIDENCE available at present indicates that " blocking mechanisms " Sjogren et al., 1971; Baldwin, Price and Robins, 1972) play a considerable role in the depression of immunity developing in the tumour bearing individual at the effector or at the target cell level. On the other hand, inappropriate or inadequate stimulation of the tumour host is implicated in the works of Evans et al. (1962) Haddow and Alexander (1964) and Haddow (1965) . A number of investigators have reported that the large pyroninophilic cell response in the paracortex of draining lymph nodes of tumour implanted animals is rapidly exhausted during tumour growth (Rosenau and Moon, 1966; Alexander et al., 1969; Edwards et alt., 1971; Chandradasa, 1973) . In certain tumour systems enhancing or blocking activity could not be detected in the serum either in vivo (Vaage, 1972) or in vitro (Deckers et al., 1973) . Evidence was presented in a previous communication (Chandradasa, 1973) that concomitant immunity developed in the host is subjected to a rapid and specific suppression during the progressive growth of tumours. In transfer studies it was also observed that the specifically cytotoxic lymphoid cells developing in the lymphoid organs of tumour implanted mice decreased either in proportion or in effectiveness during tumour bearing. These findings have been supported by the observations of a number of other workers (Vaage, 1973; Deckers et al., 1973; Whitney, Levy and Smith, 1974 We present evidence in this paper for the development of a state of hyporeactivity to the tumour within the lymph node cell population of the host during tumour bearing.
MATERIALS AND METHODS
Mice.-Inbred mice of the Balb/c strain, as previously described (Chandradasa, 1973) were used in all experiments performed in this work.
Tumour.-Tumour MC6/2 used in the present studies is a tumour line derived from the MC6 described previously (Chandradasa, 1973) by the conversion of that tumour to the ascitic form after the 15th transplant generation. Thereafter it was propagated intraperitoneally under aseptic conditions. The MC6/2, like its parental form, induced a high level of concomitant immunity during s.c. growth enabling the rejection of a challenge tumour dose of 2 x 106 cells by 16/17 mice, while the minimum overthreshold dose of 2 x 104 cells gave rise to progressively growing tumours in 100% of the normal animals. The tumour utilized in these studies was taken only from the 10th-36th transplant generations passaged in the ascitic form.
In Preparation of lymph node cell suspensions. -Ipsilateral and contralateral axillary and inguinal lymph nodes were harvested under aseptic conditions into RPMI 1640 medium and were washed twice in the same medium.
They were gently teased apart using finely pointed forceps in RPMI 1640 and the cells were passed through a 160 mesh stainless steel gauze. Cell suspensions were washed once at 250 g for 7 min and the sedimented cells were resuspended in 2 ml RPMI 1640 containing 10% heat inactivated foetal calf serum (FCS) plus 100 ,ug streptomycin and 100 i.u. benzylpenicillin per ml (RPMI/FCS). The cell viability and total viable cells/ml were determined as for tumour cells. The LNC suspensions thus prepared were used for the incorporation of tritiated thymidine.
To determine the total number of mononuclear cells present in the lymph nodes, whole nodes were first teased apart in phosphate buffered saline (PBS) using finely pointed forceps. The liberated cells were first harvested and the remaining tissue pieces were gently ground in Griffiths tubes (Baird and Tatlock Ltd, Manchester, England) using 5 ml of PBS until all the cells had been liberated. The cells were washed in 5 ml PBS, spinning at 250 g for 10 min. The cell sediment was resuspended in a suitable volume of PBS and the cell counts were performed in leucocyte diluting fluid in a Neubauer haemacytometer. The total cells obtained from lymph nodes or similarly treated spleens were then calculated.
Incorporation of 3H-TdR into lyrnphoid cells.-The lymphoid cell suspensions were diluted in RPMI/FCS medium to provide 106 cells/ml and put into sterilized plastic tubes (PT 1260, Luckham Ltd, Labro Works, Victoria Gardens, Burgess Hill, Sussex) in 0 5 ml amounts (5 x 105 cells). Tubes were prepared in quadruplicate for each set of node cells obtained from individual mice. Cell preparations with viability below 80% were discarded. 3 ,uCi of 3H-TdR (5 Ci/mmol) (Radiochemical Centre, Amersham) in 0-1 ml of RPMI/FCS was added to each tube and these were incubated in a 50 CO2 950 air atmosphere for 2 h at 37°C. The time of removal of the lymphoid organs to the start of incubation was 21-3 h (see Fig. 1 ). At the end of the incubation, 1 ml of cold (4°C) PBS was added to each tube and the tubes were washed twice at 500 g for 7 min using 1 ml of the same medium. After the second wash 1 ml of 10% trichloracetic acid ( Technique for assaying the in vivo state of stimulation of tumour bearer LNC.-The experimental procedure used for the assessment of tumour bearer LNC stimulation was previously established by the authors (Fig. 1) . It was observed that the in vitro incorporation of 3H-TdR into the in vivo stimulated LNC declined rapidly after the preparation of the cell suspensions and start of incubation. The uptake of 3H-TdR was rapid during the first 3-4 h of incubation but the rate of incorporation of the label decreased steadily during the same period. In normal LNC the slope of incorporation was similar but occurred at a much lower level compared with the sensitized LNC (see Fig. lA, B) . At the end of a 2-h incubation the incorporation of the label nearly doubled that of a one-h incubation, the 00 increases during the second h of incubation being 53% for sensitized and 410% for normal LNC. The period of incubation selected for the present experiments was found to be both satisfactory and convenient. This technique may have valuable potential for the assessment of the in vivo reactivity to tumour and other tissues and in monitoring the immune response during tumour bearing in the human disease. Fig. 2A , B and Fig. 3. It is obvious that the ct/min/ 5 x 105 cells increase, but this increment does not reflect the total activity of the lymph nodes because the total cells in nodes also increase in number. Therefore the ct/min/LNC have been multiplied by the total cell content to give the total ct/min/set of nodes.
The incorporation of 3H-TdR has been expressed as: (1) 10 and 20 days, while in terms of total stimulation the 20-day values of both ipsiand contralateral LNC were apparently elevated, although this failed to reach significance at the 50% level (0.05 < P < 0.1). There was a significant (P < 0.001) increase in the accumulated LNC in both ipsi-and contralateral lymph nodes at 20 days, which no doubt contributed to the increased total radioactivity. In mice implanted with 105 tumour cells, no significant increase of either the proportional stimulation or the indices of relative or total stimulation was noted but the total stimulation in both ipsi-and contralateral nodes was raised above the values at 10 days. This was found to be significant (0.01 < P < 0.05).
The tumours in these 2 groups of mice remained below 1 g during this period of investigation, but had more than doubled in weight between 10 and 20 days. It was also noted that their spleens had accumulated numbers of cells comparable with that present in other groups at the same stage.
In the group of mice tested at 30 days in which the tumours were initiated with an inoculum of 2 x 104 tumour cells, the ct/min/5 x 105 LNC or the relative index of stimulation in both ipsi-and contralateral nodes did not show a significant decrease below the corresponding levels at 20 days. However, the decreases in the indices of total stimulation were significant in both the ipsilateral (0.02 < P < 0.05) as well as in the contralateral nodes (0.002 < P < 0.01) as was the total ct/min in the contralateral nodes (0.002 < P < 0.01).
Effect of tumour excision on the uptake of 3H-TdR by LNC1 Tumour MC6/2 was implanted s.c. into the right flank of 14 mice. A third group of 7 mice was set aside as normal controls. Ten days later the tumours were completely excised surgically from Group I (6 mice) while Group II (8 mice) and Group III (7 mice) received sham operations. Seven days following these treatments the axillary and inguinal lymph nodes were carefully removed from the tumour excised or tumour bearing flanks of the Group I and Group II mice and from the sham operated flank of the Group III mice. The LNC preparations from the 3 groups of mice were then tested for their ability to incorporate 3H-TdR in vitro. The results of this experiment are shown in Table II . The mice in Group II bearing tumours incorporated 3H-TdR significantly more than those in Group I (P < 0.001) or those in Group III (P < 0-001) while no significant difference was noted between 3H-TdR incorporation in Groups I and III.
DISCUSSION
These results (see Table I , Fig. 2A , B and Fig. 3 ) indicate the existence of 2 different phases of stimulation of DNA synthesis within the LNC of the tumour bearing mice studied here. During the first phase, which lasted about 10 days, the stimulation of DNA synthesis bore, within limits, a direct relation to the tumour mass present. Thus, it can be seen from Table I and Fig. 2A , B that peak levels of incorporation of 3H-TdR into 5 x 105 LNC resulted in all groups of mice at 10 days. During the second phase, a marked retardation in the rate of stimulation of LNC was observed. In the groups that were implanted with the larger doses of 5 x 105 or 107 tumour cells this led to a significant decrease in the stimulation of LNC at 20 days, whereas in those that were given the smaller doses of 2 x 104 or 105 cells it resulted in a complete arrest of any further increase in the rate of stimulation of DNA synthesis. The increase in the total stimulation in these mice at 20 days resulted from an accumulation of LNC at this stage.
The specific nature of the response in the MC6/2 implanted mice is indicated by the findings on the effect of tumour excision (Table II) . These clearly show the requirement of the continued presence of tumour for the maintenance of the DNA synthetic response in lymph nodes.
These observations may indicate the presence of a mechanism of suppression or regulation of the immune response to the tumours within the tumour host. The initial period of about 10 days during which the rate of LNC stimulation steadily increased may also represent a phase during which the factors responsible for the controlling influence begin to make their appearance in the tumour host.
At present, much emphasis has been focussed on the blocking effect of antibody, antigen or their complexes either at the effector or at the target cell level. Although this is now well established, it has not always been adequate to explain the experimental results observed (Deckers et al., 1973; Vanky et al., 1973; Whitney et al., 1974 We have shown that the host's LNC response to the tumour becomes depressed soon after the early period of tumour growth. This may find an interesting correlation in the control of the delayed hypersensitivity reaction in mice painted with certain skin sensitizing agents (Asherson and Barnes, 1973; Zembala et al., 1975) . It has been shown that pretreatment of mice with the picrylating agent picryl sulphonic acid depresses or abolishes the DNA synthetic response to the same agent as well as to picryl chloride in the lymph nodes, but not in the spleen. Delayed hypersensitivity, but not the antibody response, is markedly affected, reflecting on the composition of these 2 types of lymphoid organs-the lymph nodes consisting predominantly of " T " cells while the spleen containing nearly equal proportions of both " T " and " B " cells (Raff, 1971) . Although the DNA synthetic response in the LNC of the tumour bearing mice studied here may not undergo such dramatic changes, it is nevertheless possible that a similar basis may underlie both these phenomena. It would therefore be interesting to see if such " suppressor factor(s) " could be demonstrable in the tumour hosts and if so to identify and study their immunobiochemical nature.
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